Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genotype-Guided Antiplatelet Strategy in Chinese ACS Patients
NCT02048228Phase 3Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Oct 2014
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ticagrelor in acute coronary syndrome (ACS), sponsored by Chinese PLA General Hospital. Status: unknown.
02
Drugs
ticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02048228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02048228.